HLA DR1/3/4/5, DQ Intermediate Resolution

Overview

  • EPIC Code:
  • MISC
  • Soft Test Code:
  • MSOT
  • Send Out Test Code:
  • 167120
Clinical Significance

HLA antigens may be correlated with certain disease states or other clinical conditions. Indicate in clinical information which antigen(s) is of interest. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.


Specimen Collection & Preparation

Specimen Requirements

7.0 mL Whole Blood from two (2) Lavender Top Tubes


Transport And Storage

Ambient

Protect from Extreme heat or cold

Do not Freeze


Collection Instructions


Minimum Volume


Neonatal Volume

Clinical Interpretation

Reference Range:

Refer to Interpretive Results


Methodology:
  • Sequence-based typing (SBT), sequence oligonucleotide probes (SSOP), and/or sequence-specific primer
Clinical Significance

HLA antigens may be correlated with certain disease states or other clinical conditions. Indicate in clinical information which antigen(s) is of interest. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.


Documentation

Limitations: This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).


Production Schedule

Sites Performed
  • LabCorp
Departments
  • Sendouts - Miscellaneous
Turn Around Time

3 to 7 days


Coding & Compliance

CDM

00913334


CPT Coding

81375